| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/12/2002 | CN1353614A Method of treating chronic cardiac disease |
| 06/12/2002 | CN1353610A Medicinal composition for oral administration |
| 06/12/2002 | CN1353606A IL-8 receptor antagonists |
| 06/12/2002 | CN1353605A Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and use thereof |
| 06/12/2002 | CN1353113A Active component of achyranthes root, its preparation and medical usage and its preparing process |
| 06/12/2002 | CN1353003A Process for screening active component from plant extract |
| 06/12/2002 | CN1352985A Active component of red sage root, its slowly releasing medicine and medical purpose, and its preparing process |
| 06/12/2002 | CN1352984A Chinese medicine for treating baby's congenital heart disease |
| 06/12/2002 | CN1352983A Chinese medicine for treating hypertension |
| 06/12/2002 | CN1352963A Blood pressure stabilizing pill |
| 06/12/2002 | CN1352959A Chinese medicine for treating heart disease |
| 06/12/2002 | CN1352951A Prescription of Daolu powder |
| 06/12/2002 | CN1352945A Adenosine as anti-thrombosis medicine |
| 06/12/2002 | CN1352941A 亚油酸胶囊 Linoleic acid capsules |
| 06/12/2002 | CN1352940A Licopin linoleate capsule |
| 06/12/2002 | CN1086133C Medicine for treating angitis |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith |
| 06/11/2002 | US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals |
| 06/11/2002 | US6403764 Variant wherein amino acid residue at position 16 of native-sequence human igf-1 is replaced with glycine or serine, or amino acid residue at position 25 or 49 or residues at 3 and 49 are replaced with alanine, glycine, or serine |
| 06/11/2002 | US6403650 Treatment of pulmonary hypertension |
| 06/11/2002 | US6403638 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 06/11/2002 | US6403635 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 06/11/2002 | US6403614 Such as 2-(4-(methylthiomethoxy)phenyl)-3-(4-(2-piperidin-1-yl)ethoxy) benzoyl)-6-methylthiomethoxybenzo(b)thiophene;inhibition of osteoporosis, hyperlipedemia, cancer, postmenopausal syndrome, |
| 06/11/2002 | US6403583 Anticoagulant agents for treatment and prevention of thromboembolic disorders. |
| 06/11/2002 | US6403579 Treating cardiac and cardiovascular disorders and the illnesses associated therewith, hypertension, angina pectoris, cardiac insufficiency |
| 06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
| 06/11/2002 | US6403567 To stimulate mammalian coronary vasodilatation and for imaging the heart; regadenoson |
| 06/11/2002 | US6403558 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403345 Culturing, fermentation, obtaining biomass; purification; foods, drugs, cosmetics |
| 06/11/2002 | US6403336 Dna segment encodes protective peptide-fused atriopeptin; microorganisms transformed with vectors; genetic engineering |
| 06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
| 06/11/2002 | US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | CA2239705C Quinazoline-4-one ampa antagonists |
| 06/11/2002 | CA2103666C Products containing verapamil and trandolapril |
| 06/09/2002 | WO2002067993A1 Drug-releasing system of biodegradable polymer type |
| 06/06/2002 | WO2002045431A2 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | WO2002044395A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 06/06/2002 | WO2002044383A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 06/06/2002 | WO2002044368A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 06/06/2002 | WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
| 06/06/2002 | WO2002044214A1 Methods for the synthesis of a modified hemoglobin solution |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044187A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 06/06/2002 | WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 06/06/2002 | WO2002044182A1 Condensed purine derivatives as a1 adenosine receptor antagonists |
| 06/06/2002 | WO2002044179A1 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
| 06/06/2002 | WO2002044176A1 3-substituted quinuclidines and their use as nicotinic agonists |
| 06/06/2002 | WO2002044172A1 Morpholine derivatives as antagonists of orexin receptors |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
| 06/06/2002 | WO2002044158A1 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 06/06/2002 | WO2002044154A1 Novel compounds |
| 06/06/2002 | WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | WO2002044152A1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 06/06/2002 | WO2002044149A1 Indole and dihydroindole derivatives |
| 06/06/2002 | WO2002044145A1 New mandelic acid derivatives and their use as throbin inhibitors |
| 06/06/2002 | WO2002044142A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 06/06/2002 | WO2002044141A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/06/2002 | WO2002044137A1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds |
| 06/06/2002 | WO2002044133A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors |
| 06/06/2002 | WO2002044131A1 Substituted carboxylic acid derivatives |
| 06/06/2002 | WO2002044130A1 Substituted carboxylic acid derivatives |
| 06/06/2002 | WO2002044129A1 Substituted carboxylic acid derivatives |
| 06/06/2002 | WO2002044127A1 Substituted carboxylic acid derivatives |
| 06/06/2002 | WO2002044126A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 06/06/2002 | WO2002044120A1 Compounds active at the glucocorticoid receptor iii |
| 06/06/2002 | WO2002043807A2 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction |
| 06/06/2002 | WO2002043806A2 In vivo delivery methods and compositions |
| 06/06/2002 | WO2002043786A2 Uses for medical devices having a lubricious, nitric oxide-releasing coating for the therapy of vascular disorders |
| 06/06/2002 | WO2002043764A1 Behavior chemotherapy |
| 06/06/2002 | WO2002043763A2 Combination of gaba agonists and aldose reductase inhibitors |
| 06/06/2002 | WO2002043762A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | WO2002043746A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/06/2002 | WO2002043742A1 Cyclodextrins and reversal of atherosclerosis |
| 06/06/2002 | WO2002043734A1 Novel compounds |
| 06/06/2002 | WO2002043732A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | WO2002043728A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | WO2002043721A1 Treatment of statin side effects |
| 06/06/2002 | WO2002043717A2 Treatment of varicose veins |
| 06/06/2002 | WO2002043691A1 Skin cream stimulating the surface bloodstream |
| 06/06/2002 | WO2002043664A2 Reducing cellular damage in the human body |
| 06/06/2002 | WO2002043662A2 Dietary composition containing conjugated linoleic acid and calcium for improved health |
| 06/06/2002 | WO2002043659A2 Composition containing statins and calcium for improved cardiovascular health |
| 06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | WO2002043578A2 Determination of risk and treatment of complications of prematurity |
| 06/06/2002 | WO2002043568A2 Identification of compounds that potentiate the activity of muscarinic potassium channels |
| 06/06/2002 | WO2002028895A3 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 06/06/2002 | WO2002024665A8 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 06/06/2002 | WO2002020489A3 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 06/06/2002 | WO2002020483A8 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/06/2002 | WO2002013804A3 Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid |
| 06/06/2002 | WO2002012242A3 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/06/2002 | WO2002011551A3 Oil/fat composition |
| 06/06/2002 | WO2002007716A3 Method for treating angina |
| 06/06/2002 | WO2002006299A3 Therapeutic uses for aminosterol compounds |